PANACEA BIOTEC
|
PANACEA BIOTEC Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -0.88 | -1.37 | -0.19 | -5.43 | 176.05 |
| CEPS(Rs) | 4.23 | 4.26 | 5.75 | 0.88 | 183.20 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 136.30 | 136.29 | 137.48 | 137.73 | 143.12 |
| Tax Rate(%) | 2.80 | -9.70 | 201.90 | 363.53 | 25.60 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -0.72 | -4.61 | -3.53 | -20.68 | -1.90 |
| EBIT Margin(%) | -0.20 | -0.72 | 0.89 | 3.64 | 234.47 |
| Pre Tax Margin(%) | -1.13 | -1.41 | 0.26 | 2.70 | 208.46 |
| PAT Margin (%) | -1.10 | -1.55 | -0.26 | -7.12 | 155.09 |
| Cash Profit Margin (%) | 3.98 | 4.64 | 6.19 | 1.14 | 161.39 |
| Performance Ratios | |||||
| ROA(%) | -0.56 | -0.64 | -0.11 | -2.12 | 74.05 |
| ROE(%) | -0.86 | -1.04 | -0.18 | -3.92 | 332.85 |
| ROCE(%) | -0.15 | -0.47 | 0.59 | 1.94 | 217.12 |
| Asset Turnover(x) | 0.51 | 0.41 | 0.40 | 0.30 | 0.48 |
| Sales/Fixed Asset(x) | 0.48 | 0.43 | 0.43 | 0.36 | 0.54 |
| Working Capital/Sales(x) | 3.96 | 2.68 | 3.22 | 2.04 | 3.93 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.07 | 2.35 | 2.32 | 2.79 | 1.86 |
| Receivable days | 40.93 | 42.20 | 37.70 | 54.62 | 43.66 |
| Inventory Days | 113.89 | 127.15 | 121.93 | 159.84 | 101.55 |
| Payable days | 270.26 | 339.61 | 256.06 | 297.63 | 335.05 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | - | 0.84 |
| PCE(x) | 70.04 | 103.43 | 21.10 | 123.40 | 0.81 |
| Price/Book(x) | 2.17 | 3.23 | 0.88 | 0.79 | 1.04 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 2.77 | 4.68 | 1.15 | 1.00 | 0.54 |
| EV/Core EBITDA(x) | 144.87 | -497.76 | 111.94 | -9.89 | -160.66 |
| EV/EBIT(x) | -1,339.28 | -642.00 | 126.92 | 26.56 | 0.22 |
| EV/CE(x) | 2.07 | 3.05 | 0.74 | 0.53 | 0.21 |
| M Cap / Sales | 2.84 | 4.83 | 1.33 | 1.44 | 1.37 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 14.43 | -0.01 | 21.57 | -30.44 | 5.83 |
| Core EBITDA Growth(%) | 333.05 | -191.58 | 112.39 | -1,972.34 | -102.58 |
| EBIT Growth(%) | 67.49 | -180.51 | -70.66 | -98.94 | 3,867.47 |
| PAT Growth(%) | 17.85 | -479.34 | 95.54 | -103.13 | 837.56 |
| EPS Growth(%) | 35.76 | -613.58 | 96.47 | -103.08 | 830.09 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.03 | 0.02 | 0.02 | 0.04 |
| Current Ratio(x) | 1.47 | 1.57 | 1.57 | 1.71 | 1.23 |
| Quick Ratio(x) | 0.92 | 0.99 | 1.00 | 1.09 | 0.95 |
| Interest Cover(x) | -0.22 | -1.05 | 1.41 | 3.89 | 9.01 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 |
Compare Financial Ratios of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,282.8 Cr | -0.9% | -6.5% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -0.9% |
-6.5% |
-12.1% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses
